25578/11 - Admissibility Decision
52319/22 - Legal Summary
52319/22 - Legal Summary
25578/11 - Legal Summary
25578/11 - Legal Summary
15771/20;53712/21 - Admissibility Decision
A paper co-authored by Stanford Law School’s Michelle Mello examines policies that health care organizations are implementing to address potential risks associated with cognitive and physical decline in late-career physicians (LCPs).
Stephen Luby and Jenna Forsyth have spent years examining the widespread presence of lead, including in some commonly consumed products. They discuss the prevalence of lead and share insights on food safety policies, education, and lead-free alternatives.
The academic holiday was founded in 2021 by Sean Casey, ’22, and Jonathan Lipman, ’22, with the goal of engaging students in the democratic process.
This randomized study uses electronic health record data to investigate how a monthly cash benefit delivered to low-income individuals affects emergency department and outpatient care utilization in a low-income US city.
This Viewpoint examines the implementation of the Sergeant First Class Heath Robinson Honoring Our Promise to Address Comprehensive Toxics Act, known as the PACT Act, which expanded health care for millions of veterans from any era exposed to toxic hazards.
This Viewpoint discusses the spread of medetomidine in the US illicit opioid market and the need for monitoring and a public health response.
This Viewpoint discusses the challenges to implementing artificial intelligence–based translation in clinical settings and what health care organizations can do to mitigate these challenges.
This noninferiority randomized clinical trial investigates whether tenecteplase is noninferior to alteplase for the treatment of Chinese patients with acute ischemic stroke eligible for intravenous thrombolysis within 4.5 hours after symptom onset.
In September 2023, we announced the 10th International Congress on Peer Review and Scientific Publication, to be held in Chicago, Illinois, on September 3-5, 2025. We now officially call for abstract submissions.
This Viewpoint examines how the outcome of the 2024 US presidential election could affect the future of medicine and public health, particularly the antimedicine proposals found in the Republican Party’s Project 2025 playbook.
This narrative review summarizes current evidence on the epidemiology, pathophysiology, diagnosis, and treatment of chronic spontaneous urticaria.
In Reply We appreciate Mr Meng and colleagues’ keen interest in our publication, in which we demonstrated that among individuals with clinical knee OA experiencing significant knee pain and effusion-synovitis on magnetic resonance imaging (MRI), daily supplementation with 2 g of krill oil did not improve knee pain over 24 weeks compared with placebo. Meng and colleagues raise several points, which we address in this reply.
To the Editor Dr Laslett and colleagues recently reported that daily supplementation with 2 g of krill oil in patients with knee osteoarthritis (OA) and effusion-synovitis did not alleviate knee pain over a 24-week period compared with placebo. We have several concerns about this randomized clinical trial.
In Reply In response to Dr Xu and colleagues, we performed additional analyses to examine the difference in clinical benefit of RAS blockers between Black and White patients (Table). The results were nearly identical to the findings in our main analysis comparing Black and non-Black patients, suggesting the heterogeneity across these patient groups was not substantial, as Xu and colleagues had expected.
To the Editor A recent article evaluated the efficacy of renin-angiotensin system (RAS) blockade in patients with heart failure by race, using both 1-stage and 2-stage meta-analyses, dose-response analyses, and cumulative hazard estimates. However, we have several concerns about racial classifications, Grading of Recommendations Assessment, Development, and Evaluation (GRADE) assessments, and the credibility of the reported subgroup effects.
This study uses public US Food and Drug Administration lists to identify new drugs approved from 2015 through 2021 to examine recent estimates of compliance with and timing of pediatric testing requirements after passage of the Pediatric Research Equity Act.
This Medical News story is an interview about the US Department of Veterans Affairs’ pioneering work in using artificial intelligence to improve patient care.
The application of artificial intelligence (AI) to address challenges in health care is almost universally described as transformative. Acknowledging the rapid pace at which tools incorporating AI have advanced toward clinical practice, prior JAMA editorials noted the importance of ensuring the rigorous evaluation of approaches using AI at every stage of development. It emphasized the JAMA Network’s commitment to apply the same standards and principles that would be expected for any other new technology.
